"Personalized" Test Helps Guide Cancer Treatment, U.S. Study Shows
WASHINGTON (Reuters) - A new test that looks at genetic material from a patient's tumor is 80 percent accurate in predicting which drugs would be most effective against that particular cancer, U.S. researchers reported on Sunday.